While Turnstone Biologics Corp has overperformed by 0.98%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TSBX fell by -79.96%, with highs and lows ranging from $5.75 to $0.44, whereas the simple moving average fell by -74.87% in the last 200 days.
On November 15, 2024, BofA Securities Downgraded Turnstone Biologics Corp (NASDAQ: TSBX) to Underperform. A report published by BofA Securities on October 14, 2024, Downgraded its rating to ‘Neutral’ for TSBX. Piper Sandler Initiated an Overweight rating on August 15, 2023, and assigned a price target of $20. BofA Securities initiated its ‘Buy’ rating for TSBX, as published in its report on August 15, 2023.
Analysis of Turnstone Biologics Corp (TSBX)
In order to gain a clear picture of Turnstone Biologics Corp’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -94.47% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.75, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 283.28K can be a very valuable indicator of volatility for TSBX stock. On a monthly basis, the volatility of the stock is set at 12.05%, whereas on a weekly basis, it is put at 9.73%, with a gain of 9.81% over the past seven days. Furthermore, long-term investors anticipate a median target price of $2.38, showing growth from the present price of $0.50, which can serve as yet another indication of whether TSBX is worth investing in or should be passed over.
How Do You Analyze Turnstone Biologics Corp Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 40.99%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 27.32% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
TSBX shares are owned by institutional investors to the tune of 27.32% at present.
